Retatrutide Peptide (GLP1-R)

Welcome to Buy Peptides Online USA, your premier domestic source for high-purity research peptides designed for serious scientific investigations. This product is intended strictly for laboratory research use only and is not for human or veterinary consumption. It is not a medicine, drug, or medical device and has not been evaluated by the FDA .

A Next-Generation Triple Agonist: An Introduction to Retatrutide Peptide 🔬

For researchers focused on the frontiers of metabolic disease, obesity, and energy homeostasis, Retatrutide (LY3437943) represents a groundbreaking advancement in peptide-based research tools. This synthetic 39-amino acid peptide is a novel triple agonist uniquely designed to activate all three key receptors regulating glucose homeostasis and energy balance: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR) .

Retatrutide's significance in research stems from its balanced triple agonism, which distinguishes it from earlier molecules. While semaglutide activates only GLP-1R and tirzepatide activates GLP-1R and GIPR, retatrutide is the first molecule to incorporate GCGR agonism, thereby targeting three complementary pathways involved in appetite suppression, insulin secretion, and energy expenditure . Cryo-electron microscopy (cryo-EM) structural studies have revealed that retatrutide achieves this triple agonism through a combination of maintaining common interactions with conserved receptor residues and accommodating receptor-specific sequences in the upper half of the transmembrane binding pocket .

In phase 2 clinical trials, retatrutide demonstrated substantial average weight reductions of up to 24.2% over 48 weeks in individuals with obesity, a degree of efficacy that may meaningfully impact multiple obesity-related complications . The molecule is currently being evaluated in the extensive Phase 3 TRIUMPH clinical development program, comprising four multicenter, randomized, double-blind studies assessing weekly subcutaneous retatrutide in over 5800 participants with obesity and related complications including obstructive sleep apnea (OSA) and knee osteoarthritis (OA) .

What is Retatrutide Peptide?

Retatrutide is a synthetic 39-amino acid peptide with the sequence YXQGTFTSDY SILLDKKAQX AFIEYLLEGG PSSGAPPPS, incorporating non-coded residues including Aib at positions 2 and 20, and α-methyl-Leu at position 13 . It features a C20 fatty diacid conjugation for enhanced stability and albumin binding, which extends its circulating half-life . Its molecular formula is C₂₂₁H₃₄₂N₄₆O₆₈ with a molecular weight of approximately 4731.33 Da . It is identified by CAS number 2381089-83-2 .

Its primary mechanisms of action, elucidated through extensive research , include:

1. Balanced Triple Receptor Agonism: Retatrutide potently activates GIPR (EC50 0.0643 nM), GLP-1R (EC50 0.775 nM), and GCGR (EC50 5.79 nM) . Compared to endogenous hormones, it is approximately 8.9-fold more potent at GIPR, and 0.3-fold and 0.4-fold less potent at GCGR and GLP-1R, respectively .
2. Enhanced Energy Expenditure: The unique incorporation of GCGR agonism distinguishes retatrutide from dual agonists. By activating glucagon receptors, it encourages the body to burn more calories and increases overall energy expenditure, contributing to greater weight loss than can be achieved through appetite suppression alone .
3. Regulation of Appetite and Satiety: Through GLP-1R activation, retatrutide reduces appetite and slows gastric emptying. Concurrent GIPR activation is thought to enhance the effects of GLP-1 and help regulate fat metabolism .
4. Modulation of Metabolic Pathways: The coordinated activation of its three target receptors allows retatrutide to regulate key metabolic pathways, influencing nutrient metabolism, amino acid profiles, and lipid handling .

🔬 Primary Research Focuses and Applications

The Retatrutide Peptide is at the forefront of multiple cutting-edge research areas, validated by numerous peer-reviewed studies and ongoing clinical trials:

• Obesity and Weight Management Research: Retatrutide is a premier tool for studying the effects of triple receptor agonism on body weight and adiposity. Phase 2 trials have demonstrated average weight losses of 17.5% at 24 weeks and 24.2% at 48 weeks with the 12 mg dose, representing a level of efficacy that exceeds currently approved therapies . The Phase 3 TRIUMPH program is further evaluating its safety and efficacy across over 5800 participants .

• Obstructive Sleep Apnea (OSA) Research: Given the strong association between obesity and OSA, retatrutide is being investigated for its potential to improve apnea-hypopnea index (AHI) in affected individuals. The TRIUMPH-1 and TRIUMPH-2 trials include nested protocols specifically designed to assess changes in AHI following retatrutide treatment .

• Knee Osteoarthritis (OA) Research: Retatrutide's ability to induce substantial weight reduction may have significant implications for weight-bearing joint health. The TRIUMPH program includes dedicated assessment of knee OA outcomes, with primary endpoints measuring change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score .

• Type 2 Diabetes and Glycemic Control Research: In phase 2 trials targeting type 2 diabetes, retatrutide demonstrated significant improvements in glycemic control alongside substantial weight reduction, maintaining a safety profile comparable to certain approved GLP-1RAs . A meta-analysis reported a significant mean reduction in HbA1c of -1.04% .

• Chronic Kidney Disease (CKD) Research: A 2025 systematic review and meta-analysis examined retatrutide's effects in patients with diabetes and/or obesity comorbid with CKD. Beyond glycemic and weight benefits, secondary analyses pointed toward possible renoprotective effects, evidenced by a reduction in albuminuria .

🧪 Product Specifications & Technical Data

At Buy Peptides Online USA, we ensure your research is built on a foundation of quality and consistency. This peptide is manufactured to rigorous laboratory standards and verified through advanced analytical methods.

✅ Why Choose Buy Peptides Online USA for Your Research?

Sourcing reliable research compounds is critical for reproducible, high-impact science. Here is why discerning researchers across the USA trust us:

• Verified Purity & Potency: We provide access to Certificates of Analysis (COA) and rely on advanced analytical methods like High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm the identity and purity (≥99%) of every batch . This commitment ensures the integrity of your experimental data.
• Research-Focused Integrity: We strictly adhere to research-use-only (RUO) guidelines. Our product descriptions are factual, focusing on chemical properties and cited research applications, never unverified human-use claims. This product is not for diagnostic or therapeutic use .
• Fast & Discreet USA Shipping: As a USA-based supplier, we offer fast, reliable shipping across the United States with discreet packaging to ensure your order arrives safely, professionally, and on time for your critical research timelines. Enjoy free shipping on orders over $300.
• Expert Support & Authenticity Guarantee: Our team provides technical consultation to support your work. We stand behind the authenticity and quality of all our products, offering a product replacement service and clear complaint handling.

📝 Handling, Storage, & Important Safety Information

• Critical Storage Information: Upon receipt, store the lyophilized powder at -20°C (-4°F) or below, desiccated, protected from light and moisture. It is stable for up to 3 years under these conditions . The lyophilized powder is stable at room temperature for short periods (up to 3 weeks), but long-term storage requires freezing .
• Handling for Research Use: This product is for laboratory use only by qualified professionals. Before opening, allow the vial to warm to room temperature and briefly centrifuge to concentrate material at the bottom. Reconstitute in sterile, ultra-pure water to achieve desired concentration. Gently invert to mix; do not vortex.
• Stability Considerations: Once reconstituted in a solvent, the peptide can be stored at -80°C for up to 1 year . For long-term storage of stock solutions, aliquot to avoid repeated freeze-thaw cycles, which can degrade the peptide. Avoid exposure to heat, light, and excessive agitation.
• TFA Salt Information: Peptides often contain trifluoroacetic acid (TFA) salt from the HPLC purification process. TFA contributes to total mass (peptide content typically >80% of total weight) and generally enhances solubility in aqueous solutions. For most standard in vitro assays, residual TFA levels do not cause interference .
• Safety Considerations: Retatrutide is a potent, bioactive peptide for research use only. Its safety profile in long-term studies continues to be evaluated in clinical trials . Always wear appropriate personal protective equipment (PPE), including lab coats, safety glasses, and nitrile gloves. Work in a laminar flow hood or well-ventilated area.
• Warning: This product is not for human or veterinary use. It is not a drug, food, or cosmetic. Not for human consumption or diagnostic use . For laboratory research only.

❓ Frequently Asked Questions (FAQs)

Q: What is the primary mechanism of action for Retatrutide?

A: Retatrutide is a novel triple agonist that simultaneously activates the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR) . This balanced triple agonism regulates appetite, insulin secretion, and energy expenditure.

Q: How does Retatrutide differ from other metabolic peptides like semaglutide or tirzepatide?

A: While semaglutide activates only GLP-1R and tirzepatide activates GLP-1R and GIPR, retatrutide is the first molecule to incorporate glucagon receptor (GCGR) agonism . Activation of GCGR is thought to increase energy expenditure and fat burning, contributing to the greater weight loss observed in clinical trials .

Q: What are the key research findings on Retatrutide's efficacy?

A: Phase 2 trials demonstrated average weight reductions of 24.2% over 48 weeks with the 12 mg dose . A meta-analysis reported a significant mean reduction in HbA1c of -1.04% in diabetic populations . The ongoing Phase 3 TRIUMPH program is evaluating its effects on obesity, obstructive sleep apnea, and knee osteoarthritis in over 5800 participants .

Q: What is the structural basis for Retatrutide's triple agonism?

A: Cryo-EM structural studies have revealed that retatrutide achieves triple agonism through a combination of maintaining common interactions with conserved receptor residues (including two critical salt bridges) and accommodating receptor-specific sequences in the upper half of the transmembrane binding pocket .

Q: How do you verify the purity and identity of Retatrutide?

A: We ensure every batch is rigorously analyzed using High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) . HPLC confirms a purity level of ≥99% , while Mass Spectrometry verifies the precise molecular weight (~4731.33 Da) , ensuring the correct peptide structure and identity. Certificates of Analysis (COA) are available upon request.

Q: What are the critical storage conditions for Retatrutide?

A: Store the lyophilized powder at -20°C (-4°F) or below, desiccated and protected from light and moisture; it is stable for up to 3 years under these conditions . Once reconstituted, store at -80°C for long-term storage . Avoid repeated freeze-thaw cycles.

Q: Is Retatrutide approved for clinical use?

A: Retatrutide is currently in Phase 3 clinical trials and is not approved for human use . This product is intended for legitimate laboratory research only and not for any applications involving human subjects.

Q: Is Retatrutide prohibited in sports research?

A: Researchers should be aware that retatrutide, as a peptide hormone and metabolic modulator, would be considered a prohibited substance under the general category of peptide hormones and growth factors on the World Anti-Doping Agency (WADA) Prohibited List. It is intended for legitimate scientific research only.

Ready to Advance Your Research? 🚀

Equip your laboratory with a next-generation triple agonist peptide for studying metabolic regulation, energy expenditure, and obesity-related complications. Order the high-purity Retatrutide Peptide (GLP1-R) today from Buy Peptides Online USA. Benefit from our fast USA shipping, secure payments (including crypto), and the confidence that comes from rigorously tested, research-grade compounds validated by the latest clinical research. For any questions about this product or your order, our support team is here to provide technical consultation.